New flu vaccine shows promising initial results for adults with severe obesity

A new vaccine shows promising short-term results for adults with severe obesity, potentially offering enhanced flu protection. A study involving 206 participants found this recombinant vaccine, with a higher antigen dose, generated a stronger initial immune response compared to standard vaccines. While effective initially, the enhanced protection diminished after six months, highlighting the need for further research into long-term benefits and personalized vaccination strategies.